Voltar
Artigo Revisado por pares
BIBTEX RIS

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE

2019; Springer Science+Business Media; Volume: 47; Issue: 4 Linguagem: Inglês

10.1007/s00259-019-04439-9

ISSN

1619-7089

Autores

Josephine Graf, Ulrich‐Frank Pape, Henning Jann, Timm Denecke, Ruža Arsenić, Winfried Brenner, Marianne Pavel, Vikas Prasad,

Tópico(s)

Neuroblastoma Research and Treatments

Referência(s)